Because in healthcare, bad information isnt just noise, its dangerous
12% reduction in all cause mortality with GLP-1RA in PPL with type 2 #diabetes pubmed.ncbi.nlm.nih.gov/31422062 19% reduction in all cause mortality in PPL with obesity #heartdisease nejm.org/doi/full/10.10 1) when is the last time you took someone off T2DM, HLD, or BP meds
While the alpha diversity could be modulated by XJZ, XJZ-A, and XJZ-C, but there was no significant modulation by XJZ-P
Chinas late-2024 tirzepatide approval and accompanying USD 1 billion local manufacturing commitment highlight strategic focus on domestic capacity that supports rapid volume ramp-up [3]National Medical Products Administration, Tirzepatide Approval for Type 2 Diabetes, nmpa.gov.cn
The specific function of spinal GLP-1R in DNP is not yet fully understood and necessitates additional investigation